Study of esketamine plus pregabalin and duloxetine for shingles nerve pain
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial tests whether adding esketamine to two standard pain medicines (pregabalin and duloxetine) can better treat nerve pain from shingles that persists for months. It's for people whose pain hasn't improved enough with pregabalin alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have nerve pain from shingles that has lasted more than 3 months after the rash healed
- Your average pain score is at least 4 out of 10 on a standard pain scale
- You have tried pregabalin alone without enough relief or couldn't tolerate it
- You do not have certain health conditions like sleep apnea, severe organ problems, or a history of drug abuse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of a nasal spray medicine (esketamine) and a minimally invasive procedure (pulsed radiofrequency treatment of the nerve root) to treat long-lasting pain from shingles (postherpetic neuralgia). It is for adults with moderate to severe pain that has persisted for more than 3 months.
This study tests a treatment called peripheral nerve stimulation (using a small device to send mild electrical pulses) for people with nerve pain after shingles. It's designed for those whose pain is not well managed by usual treatments.
This trial tests whether a gentle form of acupuncture (superficial needling with electroacupuncture) can relieve long-lasting nerve pain after shingles on the head and face. It may help if you have had head or face shingles and the pain has continued for a month or more.
This trial tests whether adding esketamine (a fast-acting pain medicine) to a standard nerve treatment called pulse radiofrequency (PRF) can better relieve lasting facial pain from shingles. It may help people who still have pain in the face or head after shingles.
This study tests a combination of a nasal spray medicine (esketamine) and a nerve treatment (pulsed radiofrequency) to reduce severe shingles pain. It may help people who have had shingles pain for less than 3 months and are already scheduled for the nerve procedure.
This trial tests whether adding esketamine (a medicine related to ketamine) to a standard nerve treatment (pulsed radiofrequency) can better relieve face pain caused by shingles. It may help if you have ongoing, moderate-to-severe pain in your face or scalp.
Hear when a new Postherpetic Neuralgia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.